drug discovery, done right

small molecules, global reach

What We Do

We are experts in the research and production of small molecules for the pharmaceutical industry.  We also have a 40-year legacy of research and development, the most promising of which forms our drug discovery pipeline.

Our Mission

Changing the face of disease through the accelerated advancement of our pipeline

Press Releases

August 15, 2018

Edmonton’s General Intermediates of Canada Inc. (GIC) announced today that they have received conditional funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) related to their discovery ...

June 9, 2017

Edmonton’s General Intermediates of Canada Inc. (GIC) announced today that they have successfully completed a research project related to a key starting API material for a global ...

View Press Releases

Twitter